Study of Picosecond and Nanosecond Q-switched Lasers for Tattoo Removal

Exclusion Criteria

• •Participation in a study of another device or drug within 6 months prior to enrollment or during the study
• •Prior treatment for tattoo removal in the target area, e.g., with q-switched laser, IPL, dermabrasion, electrocautery, cryotherapy
• •History of allergic reaction to pigments following tattooing
• •Presence of double tattoo in the treatment area
• •History of allergy to local anesthetics
• •History of allergy to topical antibiotics
• •History of malignant tumors in the target area
• •Skin abnormalities in the target area, e.g., cuts, scrapes, wounds, scars, large moles
• •Pregnant and/or breastfeeding
• •Having an infection, dermatitis or a rash in the treatment area
• •Significant concurrent illness, such as diabetes mellitus or cardiovascular disease, e.g., uncontrolled hypertension
• •Suffering from coagulation disorders or taking prescription anticoagulation medications
• •History of keloid scarring, hypertrophic scarring or of abnormal wound healing
• •History of immunosuppression/immune deficiency disorders or currently using immunosuppressive medications
• •History of vitiligo, eczema, or psoriasis
• •History of connective tissue disease, such as systemic lupus erythematosus or scleroderma
• •History of seizure disorders due to light
• •Any use of medication that is known to increase sensitivity to light, such as tetracycline
• •History of herpes simplex and/or herpes zoster (shingles)
• •History of radiation to the treatment area or undergoing systemic chemotherapy for the treatment of cancer
• •History of pigmentary disorders, particularly tendency for hyper- or hypo-pigmentation
• •Systemic use of corticosteroid within 12 months of study participation
• •Use of oral isotretinoin within 12 months of study participation and topical use of isotretinoin within 6 months on the treated area
• •Anytime in life, having have used gold therapy (gold salts) for disorders such as rheumatologic disease or lupus
• •Excessively tanned in areas to be treated or unable/unlikely to refrain from tanning during the study
• •Current smoker or history of smoking within 6 months of study participation
• •As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study